![IDF Clinical Focus Primary Humoral Immunodeficiency Optimizing IgG Replacement Therapy (2003) | Immune Deficiency Foundation IDF Clinical Focus Primary Humoral Immunodeficiency Optimizing IgG Replacement Therapy (2003) | Immune Deficiency Foundation](https://primaryimmune.org/sites/default/files/images/idf_02primary.jpg)
IDF Clinical Focus Primary Humoral Immunodeficiency Optimizing IgG Replacement Therapy (2003) | Immune Deficiency Foundation
![Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma | bioRxiv Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/12/21/2020.12.20.423708/F2.large.jpg)
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma | bioRxiv
![Frontiers | The role of organ-deposited IgG in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus Frontiers | The role of organ-deposited IgG in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus](https://www.frontiersin.org/files/Articles/924766/fimmu-13-924766-HTML-r1/image_m/fimmu-13-924766-g001.jpg)
Frontiers | The role of organ-deposited IgG in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus
Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave | PLOS ONE
![Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases | eLife Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases | eLife](https://iiif.elifesciences.org/lax/76223%2Felife-76223-fig2-v2.tif/full/,1500/0/default.jpg)
Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases | eLife
![Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals. - eClinicalMedicine Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals. - eClinicalMedicine](https://www.thelancet.com/cms/asset/cebb8ca1-15e1-4109-90c8-1dc2fa1f7ade/gr1.jpg)
Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals. - eClinicalMedicine
![Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients | Cellular & Molecular Immunology Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41423-020-00612-5/MediaObjects/41423_2020_612_Fig1_HTML.png)
Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients | Cellular & Molecular Immunology
![Vaccines | Free Full-Text | Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose Vaccines | Free Full-Text | Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose](https://www.mdpi.com/vaccines/vaccines-10-00153/article_deploy/html/images/vaccines-10-00153-g001.png)
Vaccines | Free Full-Text | Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose
![Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency | Gut Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency | Gut](https://gut.bmj.com/content/gutjnl/52/11/1567/F2.large.jpg)
Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency | Gut
![Frontiers | Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients Frontiers | Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients](https://www.frontiersin.org/files/Articles/724763/fimmu-12-724763-HTML/image_m/fimmu-12-724763-g001.jpg)
Frontiers | Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients
![Structure of a normal immunoglobulin (Ig) molecule. Each immunoglobulin... | Download Scientific Diagram Structure of a normal immunoglobulin (Ig) molecule. Each immunoglobulin... | Download Scientific Diagram](https://www.researchgate.net/publication/325654957/figure/fig2/AS:902315158536193@1592140106447/Structure-of-a-normal-immunoglobulin-Ig-molecule-Each-immunoglobulin-molecule-consists.jpg)
Structure of a normal immunoglobulin (Ig) molecule. Each immunoglobulin... | Download Scientific Diagram
![Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study - The Lancet Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study - The Lancet](https://www.thelancet.com/cms/asset/6a0a37e2-5f8f-415a-810d-6e89d8e0d1f3/gr1.jpg)
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study - The Lancet
![Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination | Journal for ImmunoTherapy of Cancer Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/6/1/27/F2.large.jpg)
Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination | Journal for ImmunoTherapy of Cancer
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease | PLOS Biology
![Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity | Science Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity | Science](https://www.science.org/cms/10.1126/science.abc8378/asset/5a4937bb-5887-4867-ac18-835684e1921e/assets/graphic/371_abc8378_fa.jpeg)
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity | Science
![Serological Analysis Reveals an Imbalanced IgG Subclass Composition Associated with COVID-19 Disease Severity | medRxiv Serological Analysis Reveals an Imbalanced IgG Subclass Composition Associated with COVID-19 Disease Severity | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2020/10/09/2020.10.07.20208603/F6.large.jpg)
Serological Analysis Reveals an Imbalanced IgG Subclass Composition Associated with COVID-19 Disease Severity | medRxiv
![Diagnostics | Free Full-Text | Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine Diagnostics | Free Full-Text | Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine](https://www.mdpi.com/diagnostics/diagnostics-11-01135/article_deploy/html/images/diagnostics-11-01135-g001.png)